NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

Cover of Drugs and Lactation Database (LactMed)

Drugs and Lactation Database (LactMed) [Internet].

Show details

Duvelisib

Last Revision: October 23, 2019.

CASRN: 1201438-56-3

image 164117634 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

No information is available on the clinical use of duvelisib during breastfeeding. Because duvelisib is 98% bound to plasma proteins, the amount in milk is likely to be low. However, because of its potential toxicity in the breastfed infant, the manufacturer recommends that breastfeeding be discontinued during duvelisib therapy and for at least 1 month after the last dose.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Duvelisib

CAS Registry Number

1201438-56-3

Drug Class

Lactation

Breast Feeding

Antineoplastic Agents

Enzyme Inhibitors

Kinase Inhibitors

Phosphatidylinositol 3-kinases

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Views

Related information

Similar articles in PubMed

  • Review Idelalisib[Drugs and Lactation Database (...]
    Review Idelalisib
    . Drugs and Lactation Database (LactMed). 2006
  • Review Dacomitinib[Drugs and Lactation Database (...]
    Review Dacomitinib
    . Drugs and Lactation Database (LactMed). 2006
  • Review Sorafenib[Drugs and Lactation Database (...]
    Review Sorafenib
    . Drugs and Lactation Database (LactMed). 2006
  • Review Gilteritinib[Drugs and Lactation Database (...]
    Review Gilteritinib
    . Drugs and Lactation Database (LactMed). 2006
  • Review Vismodegib[Drugs and Lactation Database (...]
    Review Vismodegib
    . Drugs and Lactation Database (LactMed). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...